Bruna Wageck 1 , Narelle S Cox 1 , 2 , 3 , Christine F McDonald 3 , 4 , 5 , Angela T Burge 1 , 2 , 3 , 6 , Ajay Mahal 7 , Catherine J Hill 3 , 8 , Annemarie L Lee 2 , 3 , 6 , Rosemary Moore 3 , 8 , Caroline Nicolson 9 , 10 , Paul O’Halloran 11 , Aroub Lahham 1 , 2 , 3 , Rebecca Gillies 1 , 8 , Anne E Holland 1 , 2 , 3 , 6
31 December 2020
Pulmonary rehabilitation is an effective treatment for people with chronic obstructive pulmonary disease (COPD), but its benefits are poorly maintained. The aim of this study was to evaluate the impact of COPD exacerbations in the year following pulmonary rehabilitation on outcomes at 12 months.
This was a secondary analysis from a trial of home versus hospital-based rehabilitation in COPD, with 12 months of follow-up. Moderate and severe exacerbations were identified using administrative data (prescriptions) and hospital records (admissions) respectively. The impact of exacerbations at 12 months following pulmonary rehabilitation was evaluated for quality of life (Chronic Respiratory Questionnaire, CRQ), dyspnea (modified Medical Research Council, mMRC), exercise capacity (6-minute walk distance, 6MWD) and objectively measured physical activity (moderate-to-vigorous physical activity, MVPA).
A total of 166 participants were included, with mean age (SD) 69 (9) years and forced expiratory volume in one second (FEV 1) 49 (19)% predicted. Moderate exacerbations occurred in 68% and severe exacerbations in 34% of participants. Experiencing a severe exacerbation was an independent predictor of worse 12-month outcomes for CRQ (total, fatigue and emotional function domains), mMRC, 6MWD and MVPA (all p<0.05). Participants who completed pulmonary rehabilitation were less likely to have a severe exacerbation (29% vs 48%, p=0.02). Severe exacerbations were more likely in those with worse baseline CRQ total (odds ratio 0.97, 95% CI 0.95 to 0.99) and FEV 1%predicted (0.98, 95% CI 0.96 to 0.99).